Literature DB >> 7333320

Technetium coordination state as a factor of stability in 99mTc-complexes used in hepatobiliary system: comparative studies on 99mTc-complexes of pyridoxal with glutamate (Tc-PG) and isoleucine (Tc-PI).

K Horiuchi, A Yokoyama, H Tanaka, H Saji, T Odori, R Morita, K Torizuka.   

Abstract

Studies on 99mTc-Penicillamine (Tc-Pen) have given us some insight into the significance of the technetium coordination state in hepatobiliary clearance behavior. A 99mTc-complex of pyridoxal and glutamate (Tc-PG) prepared by Baker et al. (1975) using an autoclaving process or by a Sn-Resin kit method (Horiuchi 1981) was compared with a 99mTc-complex of pyridoxal and isoleucine (Tc-PI) prepared by the method of Kato and Hazue (1978) through an intermediate compound of stannous ion, at room temperature. Tc-PG and TcPI complexes analyzed by thin layer chromatography, sephadex column chromatography (G-15), octanol extraction, and ligand exchange reaction showed different chemical properties. Their biological evaluation also demonstrated great differences in biodistribution in mice, metabolic studies, protein binding, and rat bile excretion. Tc-PG was estimated as an hepatobiliary agent with strong metal-ligand binding, inert to ligand exchange reaction with Pen at physiological pH; the likely occurrence of technetium in a mononuclear or dinuclear state providing the great stability observed in its biological and in vivo behavior was compared with the relatively weaker binding observed in Tc-PI, a highly lipophilic complex of high liver partition but of low stability, denoting its different chemical characteristics. The technetium coordination state in radiopharmaceuticals is responsible for the integrity of the molecule while in the blood pool and its relevance in impaired liver uptake is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7333320     DOI: 10.1007/bf00252672

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  8 in total

1.  Technetium 99m-pyridoxylideneglutamate: a new hepatobiliary radiopharmaceutical. I. Experimental aspects.

Authors:  R J Baker; J C Bellen; P M Ronai
Journal:  J Nucl Med       Date:  1975-08       Impact factor: 10.057

2.  Preparation of a chemically characterized 99mTc-penicillamine complex.

Authors:  A Yokoyama; H Saji; H Tanaka; T Odori; R Morita
Journal:  J Nucl Med       Date:  1976-09       Impact factor: 10.057

3.  Preparation of Tc-99m labeled pyridoxal-amino acid complexes and their evaluation.

Authors:  E Chiotellis
Journal:  Int J Nucl Med Biol       Date:  1977-01

4.  Technetium-99m biliary scanning agents based on pyridoxal: effect of the amino acid component on labelling and biological distribution.

Authors:  R J Baker; J C Bellen
Journal:  Int J Nucl Med Biol       Date:  1977-01

5.  [Studies on the evaluation of the clinical usefulness of 99mTc-(Sn)-pyridoxylidene isoleucine as a cholescintigraphic agent (author's transl)].

Authors:  T Odori; R Morita; H Saji; T Fujita; K Torizuka; K Horiuchi; A Yokoyama; H Matsuyama; H Muranaka
Journal:  Kaku Igaku       Date:  1979-08

6.  Tc-99m(Sn) pyridoxylideneaminates: preparation and biologic evaluation.

Authors:  M Kato; M Hazue
Journal:  J Nucl Med       Date:  1978-04       Impact factor: 10.057

7.  99Tcm chemical state in 99Tcm labeled radiopharmaceuticals--I. Preparation and biological behavior of 99Tcm-penicillamine complex with a low hydrolyzed 99Tcm state.

Authors:  A Yokoyama; H Saji; K Horiuchi; H Tanaka; T Odori; R Morita; T Mori; K Torizuka
Journal:  Int J Nucl Med Biol       Date:  1978-03

8.  Analysis of 99mTc-pyridoxylidene-glutamate complex formation and its preparation with tin-adsorbed-resin: Sn-Resin kit method.

Authors:  K Horiuchi; A Yokoyama; H Tanaka; H Saji; T Odori; R Morita; K Torizuka
Journal:  Eur J Nucl Med       Date:  1981-12
  8 in total
  1 in total

1.  Ligandin binding phthalein complexone complex of technetium for hepatic function studies.

Authors:  K Horiuchi; H Saji; Y Arano; A Yokoyama
Journal:  Eur J Nucl Med       Date:  1990
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.